Comphya is a series a startup based in Switzerland. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Comphya is a medical device company developing a novel implantable device to restore erectile function in patients non-responsive to current treatments such as PDE5 inhibitors (e.g. Viagra, Cialis) or penile injections.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky